The most favourable genotype for SSRI metabolism includes CYP2D6, CYP2C19 and SLC6A – but the findings show a low prevalence.

https://tidsskriftet.no/en/2022/09/original-article/genotyping-patients-treated-selective-serotonin-reuptake-inhibitors

Share this post